newsfilter
← Latest News
GlobeNewswire·

Traws Pharma Reports First Quarter 2025 Results and Business Highlights

FDA briefing document submitted April 24, 2025 in support of a meeting to align on pathway for tivoxavir marboxil (TXM, bird flu/seasonal flu) including potential for accelerated approval utilizing the "Animal Rule"